Literature DB >> 22572594

Misuse of medicines in the European Union: a systematic review of the literature.

Alicia Casati1, Roumen Sedefov, Tim Pfeiffer-Gerschel.   

Abstract

BACKGROUND: Although awareness of the misuse of medicines is increasing, data on the extent of the problem in the European Union (EU) are lacking.
METHODS: In order to assess the magnitude and severity of the problem, a systematic review of the literature on the misuse of analgesics, opioid substitution medicines and sedatives/hypnotics (with the exception of benzodiazepines) was conducted using the PubMed and Web of Science databases. Relevant literature was identified between 2001 and 2011.
RESULTS: The main groups of misused medicines include opioid analgesics, methadone, buprenorphine and Z-drugs. Regional trends in medicine misuse indicate heterogeneity across the EU with respect to misused medicine types and research activities. Prevalence, high-risk populations and factors contributing to medicine misuse are discussed.
CONCLUSION: The implications of these findings for prevention, treatment, and policy in the EU are considered.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22572594     DOI: 10.1159/000337028

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  53 in total

Review 1.  Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations.

Authors:  Carmen Walter; Claudia Knothe; Jörn Lötsch
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

Review 2.  Evolving paradigms in the treatment of opioid-induced bowel dysfunction.

Authors:  Jakob Lykke Poulsen; Christina Brock; Anne Estrup Olesen; Matias Nilsson; Asbjørn Mohr Drewes
Journal:  Therap Adv Gastroenterol       Date:  2015-11       Impact factor: 4.409

Review 3.  Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).

Authors:  Bianca Blanch; Nicholas A Buckley; Leigh Mellish; Andrew H Dawson; Paul S Haber; Sallie-Anne Pearson
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

4.  Detection of signals of abuse and dependence applying disproportionality analysis.

Authors:  V Pauly; M Lapeyre-Mestre; D Braunstein; M Rueter; X Thirion; E Jouanjus; J Micallef
Journal:  Eur J Clin Pharmacol       Date:  2014-11-20       Impact factor: 2.953

5.  Preventability of adverse effects of analgesics: analysis of spontaneous reports.

Authors:  Irina Cazacu; Ghada Miremont-Salamé; Cristina Mogosan; Annie Fourrier-Réglat; Felicia Loghin; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2015-03-05       Impact factor: 2.953

6.  Buprenorphine treatment for narcotic addiction: not without risks.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2015 Mar-Apr

7.  Medicines containing codeine: perspectives of medical professionals in the Republic of Ireland.

Authors:  M Foley; T Carney; R Harris; E Fitzpatrick; A Rapca-Veillet; M C Van Hout
Journal:  Ir J Med Sci       Date:  2017-01-09       Impact factor: 1.568

8.  Does Prescription Opioid Shopping Increase Overdose Rates in Medicaid Beneficiaries?

Authors:  Benjamin C Sun; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell
Journal:  Ann Emerg Med       Date:  2017-11-24       Impact factor: 5.721

9.  Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe.

Authors:  Karima Hider-Mlynarz; Philippe Cavalié; Patrick Maison
Journal:  Br J Clin Pharmacol       Date:  2018-04-02       Impact factor: 4.335

Review 10.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.